课题基金 / 基金详情

CLINICAL TRIAL: PHASE I/II STUDY OF A BOOSTER DOSE OF A/H5N1/INDONESIA/05/05 (CL

CLINICAL TRIAL: PHASE I/II STUDY OF A BOOSTER DOSE OF A/H5N1/INDONESIA/05/05 (CL
临床试验:A/H5N1 加强剂量的 I/II 期研究/INDONESIA/05/05 (CL
批准号:
7951184
负责人:
Wilbur H. Chen
金额:
$24.51万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-03-01 至 2010-06-30

项目摘要

项目成果

Wilbur H. Chen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is an NIH-sponsored multi-center phase 1-2 trial comparing the safety and immune responses of a clade 2 avian influenza vaccine in prior recipients of a clade 1 vaccine versus placebo. Subject are randomized to get either a low dose (15 ¿g) or a high dose (90 ¿g) of the vaccine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical and Biostatistics Core
  • 批准号:
    10260847
  • 项目类别:
  • 资助金额:
    $102.2万
  • 财政年份:
    2021
  • 负责人:
    Wilbur H. Chen
  • 依托单位:
Clinical and Biostatistics Core
  • 批准号:
    10471981
  • 项目类别:
  • 资助金额:
    $140.59万
  • 财政年份:
    2021
  • 负责人:
    Wilbur H. Chen
  • 依托单位:
Clinical and Biostatistics Core
  • 批准号:
    10645159
  • 项目类别:
  • 资助金额:
    $145.21万
  • 财政年份:
    2021
  • 负责人:
    Wilbur H. Chen
  • 依托单位:
Bacteriophage-based approach for managing Shigella infections
  • 批准号:
    10158437
  • 项目类别:
  • 资助金额:
    $143.97万
  • 财政年份:
    2020
  • 负责人:
    Wilbur H. Chen
  • 依托单位:
海外基金